Company profile: Jecure Therapeutics
1.1 - Company Overview
Company description
- Provider of research and development focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Jecure Therapeutics
Neurocrine Biosciences
HQ: United States
Website
- Description: Provider of therapies for neurological and endocrine-related diseases, including FDA-approved Ingrezza (valbenazine) for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa and Oriahnn (commercialized by AbbVie) for endometriosis pain and heavy menstrual bleeding associated with uterine fibroids; and investigational Crinecerfont for congenital adrenal hyperplasia due to 21-hydroxylase deficiency, NBI-1065890 (VMAT2 inhibitor), and NBI-1065845 (AMPA potentiator).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurocrine Biosciences company profile →
Omthera
HQ: United States
Website
- Description: Provider of specialty pharmaceutical therapies in clinical development for dyslipidemia and elevated triglyceride levels, serving patients at increased risk of cardiovascular disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omthera company profile →
Rare Thyroid Therapeutics
HQ: Sweden
Website
- Description: Provider of late-stage orphan drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rare Thyroid Therapeutics company profile →
Aligos Therapeutics
HQ: United States
Website
- Description: Provider of small molecule and oligonucleotide platforms and a pipeline of drug candidates for MASH and viral diseases, including COVID-19 protease inhibitors (partly funded by NIH and NIAID), a capsid assembly modulator (ALG-000184) for chronic hepatitis B, STOPSTM to reduce HBV S-antigen, and next-generation antisense oligonucleotides (e.g., ALG-020572).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aligos Therapeutics company profile →
Embark Biotech
HQ: Denmark
Website
- Description: Provider of biotech research identifying novel cell surface receptors that physiologically regulate fat tissue calorie-burning and glucose and lipid uptake; founded in 2017 and headquartered in Copenhagen, Denmark.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Embark Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Jecure Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Jecure Therapeutics
2.2 - Growth funds investing in similar companies to Jecure Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Jecure Therapeutics
4.2 - Public trading comparable groups for Jecure Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →